PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide Used as Rescue Medicine Significantly Reduced the Risk of a Severe Exacerbation Compared to Albuterol by 27% in Patients with Asthma

First time an albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations MANDALA Phase III trial results published in the New England Journal of Medicine and presented at ATS 2022 International...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials